Skip to main content
Premium Trial:

Request an Annual Quote

Chiron Acquires Sagres Discovery

NEW YORK, July 6 (GenomeWeb News) - Chiron has acquired oncogenomics firm Sagres Discovery, the companies said today.


Sagres Discovery, of Davis, Calif., has been using high-throughput genomic technologies to analyze mouse models of cancer. Based on the results, the company has assembled a set of oncology targets it calls the Oncogenome.


"With the wealth of targets from Sagres, we expect to be able to maximize the value of our collaboration with Xoma and our small molecule drug discovery program for the development and commercialization of new drugs for the treatment of cancer," commented Kenneth Bair, senior vice president and head of research at Chiron BioPharmaceuticals, in a statement.


Sagres had several collaborations, including with the Genome Institute of Singapore and Boehringer Ingelheim, both announced last year.


Neither company disclosed financial terms of the acquisition.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.